Drug development is increasingly complex, requiring rapid, informed decision-making throughout the product life cycle and across manufacturing sites. Access to a broad, deep scientific pool of pharmaceutical development expertise is especially critical when developing novel therapies, formulating for targeted patient groups, and dealing with technical challenges that can arise without warning.
Piramal Pharma Solutions responded to these needs by creating the Science Collective – a team of six highly regarded experts who serve as internal consultants and client advocates within Piramal's global operations. Functioning as a seamless, no-cost extension of the client's CMC team, these leaders help clients overcome scientific challenges and accelerate compounds through every phase, from development and manufacturing to commercialization and life cycle management.
